USFDA requests additional data on Sanofi Dupixent for treating smoker's lung Ruchika Sharma31 May 2024 3:16 PM ISTParis: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...
Higher Waist Circumference Linked to Increased Risk of Asthma Attacks, States study Dr Riya Dave30 May 2024 8:30 PM ISTResearchers have found a significant correlation between waist circumference and the likelihood of experiencing asthma attacks in adults. This study...
Nivolumab with chemotherapy improve outcomes in resectable non-small-cell lung cancer: NEJM Jacinthlyn Sylvia29 May 2024 10:00 PM ISTA new phase 3 clinical trial revealed that standard treatment with neoadjuvant nivolumab in combination with chemotherapy significantly improved the...
Bisoprolol fails to improve outcomes in COPD patients at high risk of exacerbations: BICS trial Medha Baranwal28 May 2024 9:45 PM ISTUK: In a landmark advancement in managing chronic obstructive pulmonary disease (COPD), the findings of the BICS (Bisoprolol in COPD Study) randomized...
Antenatal corticosteroid use reduces respiratory morbidity in babies born in the late preterm period: Study Medha Baranwal28 May 2024 8:15 PM ISTNigeria: The administration of antenatal corticosteroids (ACS) has long been considered a cornerstone in preterm labor management, aimed at improving...
Galectin 3 promising biomarker for predicting long COVID among patients of Covid 19: Study Dr Riya Dave28 May 2024 8:30 AM ISTResearchers have found that Galectin-3 could serve as a reliable biomarker for predicting post-COVID syndrome, especially when measured 60 to 120 days...
Azithromycin fails to Improve Outcomes in Preterm Infants at Risk of chronic lung disease of prematurity: Lancet Dr Riya Dave28 May 2024 8:00 AM ISTResearchers have found that prophylactic azithromycin does not improve survival rates or reduce the incidence of chronic lung disease of prematurity...
Pamrevlumab Shows No Significant Benefit in Slowing Lung Function Decline in Idiopathic Pulmonary Fibrosis: JAMA Dr Riya Dave27 May 2024 8:00 AM ISTResearchers have found that pamrevlumab, a monoclonal antibody, does not significantly slow the decline in lung function for patients with idiopathic...
Dupilumab lowers exacerbations in COPD and type 2 inflammation and improves lung function: NEJM Dr. Kamal Kant Kohli25 May 2024 8:15 AM ISTChronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug-dupilumab-that showed rapid and sustained...
Ventilatory assistance before umbilical cord clamping fails to improve outcomes for extremely preterm infants: JAMA Medha Baranwal24 May 2024 8:00 PM ISTUSA: In a groundbreaking development in neonatal care, a randomized clinical trial (RCT) has demonstrated the significant benefits of providing...
Specialized Care of Undiagnosed Asthma and COPD Patients Halves Healthcare Utilization and symptom burden: NEJM Dr Riya Dave24 May 2024 8:30 AM ISTResearchers have found that identifying symptomatic individuals with undiagnosed asthma and chronic obstructive pulmonary disease (COPD) and linking...
New tool may help identify infants at high risk for poor RSV outcomes, reveals study Dr. Kamal Kant Kohli24 May 2024 7:30 AM ISTOn the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool...
